PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.050
-0.010 (-0.94%)
At close: Jun 20, 2025, 4:00 PM
1.060
+0.010 (0.95%)
After-hours: Jun 20, 2025, 4:00 PM EDT
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$4,987,515
Market Cap
7.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PMCB News
- 1 year ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 1 year ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 1 year ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 1 year ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire
- 2 years ago - PharmaCyte Biotech Announces Final Results of Tender Offer - Business Wire
- 2 years ago - PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share - Business Wire
- 2 years ago - PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Business Wire
- 2 years ago - PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value - GlobeNewsWire